AI can generate 100x more drug candidates, but trials still need real patients. The bottleneck has shifted, and most sponsors ...
FDA clears Haemonetics PerQseal Elite vascular closure system for large-bore arterial procedures, showing zero major ...
UP Oncolytics secures $2.5M NIH funding to advance engineered Zika virus glioblastoma therapy toward first human trial, ...
SpyGlass Pharma's Bimatoprost Pad-IOL demonstrates four-year durability in first-in-human trial, supporting two ongoing Phase ...
J&J's icotrokinra hit every UC endpoint in NEJM's Oct 2026 data, and the trial design choices behind that success are ...
FDA granted four DMD antisense oligonucleotide accelerated approvals on ~1 percentage-point dystrophin increases. With $967M ...
ArriVent's firmonertinib Phase 1b data published in Cancer Cell, targeting EGFR PACC mutations resistant to standard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results